持续肺动脉高压,persistent pulmonary hypertension
1)persistent pulmonary hypertension持续肺动脉高压
1.Advances in diagnosis and treatment on neonatalpersistent pulmonary hypertension;新生儿持续肺动脉高压诊治的若干进展
2.Clinical study of phentolamine onpersistent pulmonary hypertension of the newborn;酚妥拉明治疗新生儿持续肺动脉高压
3.persistent pulmonary hypertension of newborn (PPHN), Which is a clinical syndrome, characterized by various pathogeny secondary to maintain elevated pulmonary vascular resistance after birth with resultant shunting of pulmonary blood flow to the systemic circulation by across patent foramen oval(PFO) and/or patent ductus arteriosus(PDA).一、目的： 新生儿持续肺动脉高压(persistent pulmonary hypertension of newborn，PPHN)是指出生后，因各种病因导致肺血管阻力持续增加引起肺动脉压高于体循环压，右心腔静脉血流通过卵园孔和/或动脉导管，产生大量的右向左分流，是多种因素所致的临床综合症。
英文短句/例句
1.Diagnosis and Treatment of Persistent Pulmonary Hypertension in Newborn Infants新生儿持续肺动脉高压的诊断和治疗
2.The Study on Risk Factors for Persistent Pulmonary Hypertension of Newborn;新生儿持续肺动脉高压高危因素的研究
3.Clinic and Experimental Work on Mechanical Ventilation in Treatment of Persistent Pulmonary Hypertension of Newborn;机械通气治疗新生儿持续肺动脉高压症的临床与实验研究
4.A Comparison Study of Using Sildenafil on Persistent Pulmonary Hypertension of the Newborn西地那非治疗新生儿持续肺动脉高压比对研究(英文)
5.Magnesium Sulfate Combined with Mechanical Ventilation Therapy on Persistent Pulmonary Hypertension in 36 Newborns硫酸镁联合机械通气治疗新生儿持续肺动脉高压36例
6.Clinical evidence of treatment for persistent pulmonary hypertension of the newborn新生儿持续性肺动脉高压治疗的临床证据
7.Continuous Administration of Adenosine by Peripheral Pathway Attenuate Myocardial Hypertrophy and Pulmonary Arterial Hypertension Induced by Hypoxia in Rats腺苷外周持续给药拮抗大鼠低氧性右心肥厚及肺动脉高压
8.The protective effect of pulmonary artery perfusion with oxygenated blood on the lungs during extracorporeal circulation心肺转流肺动脉持续灌注氧合血的肺保护作用
9.Changes of Calponin and TGFβ1 in Pulmonary Artery Smooth Muscle Cells of Pulmonary Artery Hypertension Rats;肺动脉高压大鼠肺动脉平滑肌上calponin和TGFβ1的变化
10.Expression of Chymase in Pulmonary Artery Reconstruction of Pulmonary HypertensionChymase在肺动脉高压疾病的肺动脉重构中的表达
11.Effect of Feixinping on ET and NOSmRNA Expression in Pulmonary Artery in Rats with Pulmonary Hypertension in Pulmonary Heart Disease肺心平对肺心病肺动脉高压大鼠肺动脉ET和NOSmRNA表达的影响
12.Clinical analysis of 7 cases of portopulmonary hypertension门脉高压相关性肺动脉高压7例临床分析
13.Mechanism for 5-HT on Monocrotaline-induced Pulmonary Hypertension and Peucedanum Praeruptorum Dunnon Inhibited Pulmonary Arterial Hypertension;MCT诱导肺动脉高压的5-HT机制及Pd降低肺动脉高压作用
14.Effects on RhoA/Rho Kinase on High Pulmonary Flow Induced Pulmonary Hypertension;RhoA/Rho激酶对高肺血流大鼠肺动脉高压的作用
15.Sildenafil Prevents and Reverses the Development of Pulmonary Hypertension in Pneumonectomy Combining to Monocrotaline Treated Rats;西地那非对肺动脉高压大鼠肺动脉压力影响的实验研究
16.Study of the Regulation Effects of Oridonin on Pulmonary Artery Pressurein Pulmonary Hypertension Rats with Chronic Hypoxia-hypercapnia and Its Mechanism冬凌草甲素对肺动脉高压大鼠肺动脉压的调控作用及机制研究
17.Effect of Fractalkine on Hypoxic Pulmonary Hypertension;Fractalkine在低氧性肺动脉高压中的作用
18.Left Ventricular Function of Rabbit Model with Pulmonary Hypertension Monitored by Echocardiography;兔肺动脉高压左心功能的变化及意义
相关短句/例句
Persistent pulmonary hypertension of the newborn新生儿持续肺动脉高压
3)Continuous pulmonary perfusion肺动脉持续灌注
4)continuous pulmonary perfus ion持续肺动脉灌注
5)Pulmonary arterial hypertension肺动脉高压
1.NO and pulmonary arterial hypertension;一氧化氮与肺动脉高压的关系研究进展
2.Pharmacology and clinical study of ambrisentan for treatment of pulmonary arterial hypertension;治疗肺动脉高压新药安贝生坦的药理与临床研究
3.Clinic Study on Shenfu Injection to Treat Pulmonary Arterial Hypertension of Chronic Cardiopulmonary Disease;参附针治疗慢性肺心病肺动脉高压症的临床研究
6)Pulmonary artery hypertension肺动脉高压
1.Effects of Enalapril or Metoprolol on plasm brain natriuretice peptide in congenital heart disease combined with pulmonary artery hypertension after transcatheter closure;经导管封堵对先天性心脏病伴肺动脉高压患者血浆脑钠素的影响及其药物干预研究
2.Preparation and identification of animal model with hypoxia-induced pulmonary artery hypertension;急性缺氧型肺动脉高压动物模型制备
3.Clinical observation on the left ventricular myocardial remodel and dysfunction in children with congenital heart disease and hypoxia-induced pulmonary artery hypertension.;先天性心脏病肺动脉高压患儿左室心肌重塑和舒张功能的临床观察
延伸阅读
肺动脉高压肺动脉高压pulmonaryhypertension肺循环压力高于正常的病理状态。多并发于心肺疾病，也可由肺血管病本身引起。临床上不少见。肺动脉高压可致右心室肥厚或肺源性心脏病。静息状态下肺动脉平均压＞2.67千帕（kPa）（20毫米汞高）或收缩压＞4.00kPa（30毫米汞高）。为肺动脉高压。病理生理肺毛细血管和/或左房压力升高、肺血管床总截断面积下降、肺动脉血流量增加、缺氧等是引起肺动脉压力升高的重要因素。当上述因素持续存在并达到一定程度时，肺血管发生形态学改变。肺动脉和静脉中层肥厚，内膜增生，管径变小，增加了肺血管阻力，产生肺动脉高压。病因及分类①原发性肺动脉高压，病因不清。可能与先天性肺小动脉病变、肺小动脉痉挛或自身免疫等因素有关。②继发性肺动脉高压，由已知病因引起，如肺气肿、肺纤维化及肺血栓栓塞；左向右分流的先天性心脏病、二尖瓣病变、心包积液等。临床表现和体征易疲乏，有劳力性呼吸困难、晕厥、咯血等；颈静脉搏动增强，肺动脉瓣区收缩期搏动，肺动脉第二音增强或分裂，有收缩期喷射音和喷射性杂音；右心衰竭后出现相应症状。心电图可出现电轴右倾、肺型P波、右室肥厚和右束支传导阻滞，胸部X射线检查显示肺动脉段突出、右下肺动脉增宽等，超声心动图示右房右室增大及肺动脉高压征象。治疗处理原发病及有关影响因素，选用血管扩张药降低肺动脉压力。
